GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ABT-267 | ABT267 | compound 38 [PMID: 24400777] | Technivie® (ombitasvir  + paritaprevir  + ritonavir) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
                                 ombitasvir is an approved drug (FDA (2015), EMA (2020)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Ombitasvir is an orally available, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [1]. In common with many other NS5A inhibitors it is a dinucleotide derivative.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| References | 
| 1. DeGoey DA, Randolph JT, Liu D, Pratt J, Hutchins C, Donner P, Krueger AC, Matulenko M, Patel S, Motter CE et al.. (2014) Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A. J Med Chem, 57 (5): 2047-57. [PMID:24400777] |